Literature DB >> 6311412

Staging and prognostic factors in small cell carcinoma of the lung.

K Osterlind, D C Ihde, D S Ettinger, R J Gralla, K Karrer, S Krauss, L H Maurer, M Rørth, S Sörenson, R Vincent.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6311412

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  5 in total

1.  Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.

Authors:  K Beiske; A T Myklebust; S Aamdal; R Langholm; E Jakobsen; O Fodstad
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.

Authors:  S G Allan; A Gregor; M A Cornbleet; R C Leonard; J F Smyth; I W Grant; G K Crompton
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.

Authors:  Farrah J Mateen; Aminah Jatoi; Timothy W Lineberry; Dawn Aranguren; Edward T Creagan; Gary A Croghan; James R Jett; Randolph S Marks; Julian R Molina; Ronald L Richardson
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

4.  Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer.

Authors:  Soojung Hong; Young Ae Kang; Byoung Chul Cho; Dae Joon Kim
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

5.  Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).

Authors:  L G Jørgensen; K Osterlind; H H Hansen; E H Cooper
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.